TRIMARCHI, Francesco
 Distribuzione geografica
Continente #
EU - Europa 20.881
NA - Nord America 17.323
AS - Asia 10.657
SA - Sud America 3.831
AF - Africa 310
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 19
Totale 53.042
Nazione #
US - Stati Uniti d'America 17.040
RU - Federazione Russa 10.197
SG - Singapore 4.818
BR - Brasile 3.301
CN - Cina 2.933
IE - Irlanda 2.477
SE - Svezia 2.196
IT - Italia 1.609
HK - Hong Kong 1.091
DE - Germania 1.088
UA - Ucraina 930
FR - Francia 744
VN - Vietnam 599
FI - Finlandia 532
GB - Regno Unito 521
IN - India 296
AR - Argentina 198
BD - Bangladesh 128
CA - Canada 106
MX - Messico 106
TR - Turchia 106
IQ - Iraq 101
EC - Ecuador 91
CO - Colombia 81
NL - Olanda 78
PL - Polonia 77
ZA - Sudafrica 74
BE - Belgio 73
PK - Pakistan 65
AT - Austria 62
UZ - Uzbekistan 60
MA - Marocco 58
JP - Giappone 55
CI - Costa d'Avorio 52
ES - Italia 49
ID - Indonesia 49
CZ - Repubblica Ceca 48
VE - Venezuela 47
TN - Tunisia 37
CH - Svizzera 35
SA - Arabia Saudita 35
AE - Emirati Arabi Uniti 33
IR - Iran 32
CL - Cile 27
UY - Uruguay 27
PY - Paraguay 25
DO - Repubblica Dominicana 22
DZ - Algeria 22
KE - Kenya 22
KZ - Kazakistan 22
AL - Albania 20
AZ - Azerbaigian 19
EG - Egitto 19
JO - Giordania 19
LB - Libano 18
NP - Nepal 18
RO - Romania 18
AU - Australia 17
PE - Perù 17
KG - Kirghizistan 16
BO - Bolivia 15
IL - Israele 15
LT - Lituania 15
PH - Filippine 15
MY - Malesia 13
PS - Palestinian Territory 13
PT - Portogallo 12
BG - Bulgaria 11
EU - Europa 11
GR - Grecia 11
JM - Giamaica 11
HU - Ungheria 10
QA - Qatar 10
BH - Bahrain 8
CR - Costa Rica 8
DK - Danimarca 8
GE - Georgia 8
OM - Oman 8
RS - Serbia 8
TH - Thailandia 8
BY - Bielorussia 7
KR - Corea 7
SN - Senegal 7
SY - Repubblica araba siriana 7
EE - Estonia 6
ET - Etiopia 6
GT - Guatemala 6
HR - Croazia 6
LV - Lettonia 6
MD - Moldavia 6
SK - Slovacchia (Repubblica Slovacca) 6
MN - Mongolia 5
PA - Panama 5
TT - Trinidad e Tobago 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
BN - Brunei Darussalam 4
LU - Lussemburgo 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
Totale 52.983
Città #
Moscow 3.005
Dublin 2.469
Singapore 2.404
Ashburn 2.349
Dallas 1.988
Chandler 1.870
Jacksonville 1.868
Nyköping 1.096
Hong Kong 1.084
Beijing 1.044
San Jose 573
The Dalles 531
Princeton 462
Dearborn 452
Cambridge 436
Los Angeles 422
Lauterbourg 411
Medford 361
Des Moines 347
Ann Arbor 290
New York 276
Munich 243
São Paulo 241
Boardman 224
Buffalo 216
Ho Chi Minh City 188
Messina 180
Lancaster 161
Wilmington 149
Tianjin 143
Jinan 131
Woodbridge 122
Hanoi 111
Milan 111
Guangzhou 110
Shenyang 107
San Mateo 106
Rio de Janeiro 96
Redondo Beach 90
Nanjing 88
Orem 84
Frankfurt am Main 83
Rome 80
Hyderabad 75
Catania 73
Houston 73
Brussels 72
Turku 68
Belo Horizonte 66
Bremen 66
Seattle 65
Council Bluffs 62
Brasília 60
Zhengzhou 60
Tashkent 57
Santa Clara 56
Porto Alegre 53
Pune 53
Abidjan 52
London 51
Warsaw 50
Dong Ket 48
Tokyo 48
Shanghai 46
Haikou 44
Hangzhou 43
Hebei 43
Chennai 42
Helsinki 41
Johannesburg 41
San Francisco 40
Stockholm 39
Denver 38
Ningbo 38
Shenzhen 38
Taizhou 38
Curitiba 37
Düsseldorf 36
Montreal 36
Vienna 36
Brooklyn 35
Falls Church 35
Turin 35
Fortaleza 34
Mumbai 34
Nanchang 34
Baghdad 33
Salvador 33
Guayaquil 31
Ribeirão Preto 30
Bologna 28
Boston 28
Fuzhou 28
Goiânia 28
Norwalk 28
Toronto 28
Brno 27
Chicago 27
Haiphong 27
Bogotá 26
Totale 29.295
Nome #
I LIVELLI SIERICI DI INTERLEUCHINA 23 (IL-23) SONO AUMENTATI NEI PAZIENTI CON TIROIDITE DI HASHIMOTO (TH) DI NUOVA DIAGNOSI RISPETTO AI CONTROLLI SANI 704
IL GRADO DI COINVOLGIMENTO CUTANEO, VALUTATO COME SKIN SCORE SECONDO RODNAN, NEI PAZIENTI CON SCLEROSI SISTEMICA (SS) CORRELA CON I LIVELLI SIERICI DI TSH 321
99mTc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology 269
131I RADIOIODINE THERAPY (RIT) OF HYPERTYROIDISM DUE TO GRAVES’ DISEASE (GD) OR UNI-MULTINODULAR TOXIC GOITER (NTG): OUR EXPERIENCE 254
131I Radioiodine therapy (RIT) of hyperthyroidism due to Graves' disease (GD) or uni-multinodular toxic goiter (NTG): our experience 244
3D representation of human shoulder using volume rendering techniques. 234
Acute liver damage following intravenous glucocorticoid treatment for Graves’ ophthalmopathy 234
Refractoriness of two novel formulations of L-T4 (oral solution and soft gel capsule) to the coffee-induced intestinal absorption of tablet L-T4. 233
antiphospholipid antibodies syndrome associated with hyperhomocysteinemia related to MTHFR Gene C677T and A1298C heterozygous mutations in a young man with idiopathic hypoparathyroidism (DiGeorge syndrome). 228
Annual increase in the frequency of papillary thyroid carcinoma as diagnosed by fine-needle aspiration at a cytology unit in Sicily. 228
Prospective study on the triggering role of stress in Graves' disease. 224
Cardiovascular outcomes and conventional risk factors in nondiabetic adult patients with GH deficiency: a long-term retrospective cohort study 223
3 NEW MUTATIONS OF THYROID-HORMONE RECEPTOR-BETA ASSOCIATED WITH RESISTANCE TO THYROID-HORMONE 218
A case of congenital goiter in an endemic area: histological, immunohistochemical and ultrastructural observations]. 218
Coffee impairs intestinal absoprtion of levo-thyroxine: report of additional cases. 216
Studio prospettico sul ruolo degli eventi stressanti (ES nello scatenamento degli episodi di ipertiroidismo da morbo di Basedow (MB). 214
I livelli sierici di interleuchina 22 (IL-22) sono aumentati nella tiroidite di Hashimoto rispetto alle tireopatie non autoimmuni ed ai controlli sani. 204
Cardiovascular events in acromegaly: distinct role of Agatston and Framingham score in the 5-year prediction. 204
A patient with stress-related onset and exacerbations of Graves disease. 202
Changes in both size and cytological features of thyroid nodule after levothyroxine treatment. 199
DETECTION OF MATERNAL THYROID FAILURE DURING PREGNANCY: SCREENING OR MONITORING? 198
A novel formulation of L-thyroxine (L-T4) solves problems of L-T4 malabsorption caused by coffee in patients under replacement or TSH suppressive L-T4 therapy with conventional tablets. 198
A case of clinically silent acromegaly with erectile dysfunction. 194
Coffee Impairs Intestinal Absorbtion of Levothyroxine: Report of Additional Cases 192
A liquid formulation of L-thyroxine (L-T4) solves problems of incomplete normalization/suppression of serum TSH caused by proton pump inhibitors (PPI) on conventional tablet formulations of L-T4. 192
Cell proliferation parameters and apoptosis indices in pituitary macroadenomas 190
Immunoreactions for P53 isoforms are associated with ultrastructural proliferative profiles in benign thyroid nodules 189
Association of autonously functioning ("hot") thyroid nodules with Hashimotos' thyroiditis (HT). 188
[Thyro-gastric autoimmunity in a pediatric population of type-I diabetics] 188
A novel formulation of l-thyroxine (l-T4) reduces the problem of l-T4 malabsorption by coffee observed with traditional tablet formulations 188
AN UNUSUAL CASE OF MARINE-LENHART SYNDROME. 187
Changes in hormonal and metabolic parameters in transgender subjects on cross-sex hormone therapy: A cohort study 187
ABLAZIONE RADIOMETABOLICA DEL RESIDUO TIROIDEO POST-CHIRURGICO DOPO STIMOLO CON TSH UMANO RICOMBINANTE (rhTSH) IN PAZIENTI CON OFTALMOPATIA DI GRAVES (OG) DI GRADO MODERATAMENTE SEVERO E SEVERO: STUDIO PROSPETTICO RANDOMIZZATO IN SINGOLO CIECO 186
Association of parathyroid carcinoma and thyroid disorders: A clinical review 185
Attention deficit and hyperactivity disorders in the offspring of mothers exposed to mild-moderate iodine deficiency: A possible novel iodine deficiency disorder in developed countries 184
Clinico-pathological significance of cell-type-specific loss of heterozygosity on chromosome 7q21: analysis of 318 microdissected thyroid lesions 183
Allelic loss at 7q21 is a frequent and early event in thyroid follicular tumors. 183
Increased annual frequency of Hashimoto's thyroiditis between years 1988 and 2007 at a cytological unit of Sicily. 183
Interference of L-T4 absorption by proton-pump inhibitors (PPIs) can be solved by a liquid ormulation of L-thyroxine (L-T4). 181
Central nervous system vasculitis after starting methimazole in a woman with Graves' disease 180
Course of Pregnancy in Cushing Disease under Different Management Approaches (No Treatment, Surgery, Gamma-Knife or Ketoconazole) 179
Peptide receptor radionuclide therapy with 111IN-DTPA-Octreotide in a woman with Cabergoline-resistant giant prolactinoma 178
AUMENTATO STRESS OSSIDATIVO NELLA TIROIDITE DI HASHIMOTO (TH) CON EUTIROIDISMO 178
BRAFV600Emutation is associated with increased prevalence of contralateral lymph-node metastases in low and low-to-intermediate risk papillary thyroid cancer 177
Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor 176
CD30 and CD30 ligand (CD30L) expression in decidual samples of spontaneous abortions. 176
Analisi immunoistochimica dei "pathways" del sistema HGF/c-met in noduli tiroidei benigni e maligni. 176
Acromegalic cardiopathy: a morphofunctional study with color-Doppler echocardiography 176
Deficit di ormone della crescita e sindrome metabolica: effetti del trattamento sostitutivo a lungo termine con GH ricombinante in età adulta. 175
Effects of maternal iodine nutrition and thyroid status on cognitive development in offspring: A pilot study 175
Effectiveness and safety of long-term pegvisomant administration in patients with acromegaly not controlled by other therapies: experience of an Italian center. 174
Un caso di orticaria cronica idiopatica (OCI) associata a morbo di Basedow (MB): tipizzazione HLA. 174
Attention Deficit and Hyperactivity Disorders due to Iodine Deficiency: A Novel Iodine Deficiency Disorder Affecting the Offspring of Hypothyroxinemic Mothers 173
A miRNA signature associated with human metastatic medullary thyroid carcinoma. 173
A novel point mutation in the ligand-binding domain of the human glucocorticoid receptor (hGR)in a patient with glucocorticoid resistance 171
Analisi immunoistochimica dell'espressione dlel'epidermal growth factor receptor (EGFR) e di HER2 nel carcinoma midollare della tiroide (MCT). 171
Increased prevalence of acromegaly in a highly polluted area. 171
The changing phenotype of iodine deficiency disorders: a review of thirty-five years of research in North-Eastern Sicily 171
Additional cases of impairment of L-thyroxine (L-T4) intestinal absorption caused by coffee. 170
I livelli sierici di Interleuchina 37 (IL-37) sono aumentati nella Tiroidite di Hashimoto (TH) e correlano con i marcatori di stress ossidativo 170
Braf V600E and 99m-TC MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy. 170
Combined BRAFV600Eanalysis and99mTc-MIBI scintigraphy can be a useful diagnostic tool in differentiated thyroid cancer patients with incomplete bio-chemical response to first radioiodine therapy (RAIT): a pilot investigation 170
A Novel Iodine Deficiency Disorder: Gestational Hypothyroxinemia – How Safe is it for Progeny? 168
ACCUMULO DI RADIOIODIO IN MIELOMENINGOCELE SECONDARIO A SPINA BIFIDA OCCULTA: PRIMA EVIDENZA DI CONDIZIONE SIMULANTE UNA METASTASI VERTEBRALE DI CARCINOMA DIFFERENZIATO DELLA TIROIDE 168
Association of primary hyperparathyoidism (p-hyperPTH) with nodular toxic goiter (NTG): a prospective study at an outpatient osteoporosis service. 167
Association of primary hyperparathyroidism (p-hyperPTH) with nodular toxic goiter (NTG) 167
Increased serum interleukin-22 levels in patients with PRL-secreting and non-functioning pituitary macroadenomas. 167
Aplotipi del microsatellite D7S6440, localizzato nell'introne 9 del gene HIPK2, come marcatori molecolari della tiroidite di Hashimoto 167
Abnormalities of GH secretion in a young girl with Floating-Harbor syndrome 163
Very High Frequency of the Polymorphism for the Insulin Receptor Substrate 1 (IRS-1) at Codon 972 (Glycine972Arginine) in Southern Italian Women with Polycystic Ovary Syndrome. 163
Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL. 163
Oxidative Stress and Advanced Glycation End Products in Hashimoto's Thyroiditis 163
Malattie della Tiroide-Note di anatomia e fisiologia 162
Association of autonomously functioning thyroid nodules (AFTNs) with Hashimoto's thyroiditis (HT) 162
Lymphocytic hypophysitis: differential diagnosis and effects of high-dose pulse steroids, followed by azathioprine, on the pituitary mass and endocrine abnormalities--report of a case and literature review. 161
Attention deficit and hyperactivity disorders (ADHD) in the offspring of mothers exposed to iodine deficiency: a possible novel iodine deficiency disorder in developed countries 160
Association between primary hyperprathyroidism (p-hyperPTH) and nodular toxic goiter (NTG): a prospective study at an outpatient service for osteoporosis 160
Myopathy as the persistently isolated symptomatology of primary autoimmune hypothyroidism 160
Expression of the hepatocyte growth factor and c-met in normal thyroid, non-neoplastic, and neoplastic nodules 160
Course of pregnancies in women with Cushing's disease treated by gamma-knife 160
Abla zione radiometabolica dopo rhTSH del residuo tiroideo post -chirurgico in pazienti con orbitopatia di Graves moderatamente severa e severa 160
Gly972Arg of IRS-1 and Lys121Gln of PC-1 polymorphisms act in opposite way in polycystic ovary syndrome 160
MRI finding of simultaneous coexistence of growth hormone-secreting pituitary adenoma with intracranial meningioma and carotid artery aneurysms: report of a case 159
Increased frequency of the rs2066853 variant of aryl hydrocarbon receptor gene in patients with acromegaly 159
Abnormal daily periodicity of serum thyrotropin (TSH) and evidencefor defective TSH suppression in a case of non-neoplastic syndrome ofinappropriate TSH secretion. 158
Predictive markers of recurrence in radically resected pituitary macroadenomas 157
A radioimmunoassay for thyroxine in unextracted serum 157
Follicular variant of papillary thyroid carcinoma presenting as toxic nodule in an adolescent: coexistent polymorphism of the TSHR and Gsα genes 157
Autoimmune comorbidities in Hashimoto's thyroiditis: different patterns of association in adulthood and childhood/adolescence 156
Correlation of cardio-metabolic parameters with vitamin D status in healthy premenopausal women 156
A congenitally hypothyroid young man (Seated Dwarf, Goya’s Studio, 19th century) 156
Looking for Increased Prevalence of Hashimoto's Thyroiditis (HT)in Patients with Sarcoidosis (SAR)and Finding an Increased Rate of High Serum Levels of Thyroxine-binding Globulin (TBG)with Presumably Impaired Binding Property. 155
Thyroid metastases from renal cell carcinoma: review of the literature. 154
CARATTERISTICHE CLINICHE ED ISTOLOGICHE DI UNA SERIE RETROSPETTIVA DI 455 PAZIENTI AFFETTI DA CARCINOMA DIFFERENZIATO DELLA TIROIDE 154
HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies. 154
Trattamento di tumori ipofisari mediante Cyber-Knife: Dati preliminari a medio termine su efficacia e sicurezza 153
Expressions of Δ 133 isoforms of P53 in multinodular thyroids: the immunoreactions in benign lesions are correlating with subcellular phenotypes of electron microscopy 153
Associazione tra noduli tiroidei iperfunzionanti (noduli "caldi") e tiroidite di Hashimoto 152
Association of primary hyperparathyroidism (p-hyperPTH) with nodular toxic goiter (NTG): a prospective study at an outpatient osteoporosis service 152
Association of autonomously functioning thyroid nodules with Hashimoto’s thyroiditis: study on a large series of patients 152
Totale 18.706
Categoria #
all - tutte 168.962
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 168.962


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021673 0 0 0 0 0 0 0 0 0 263 242 168
2021/20223.054 31 463 58 161 123 36 181 136 77 450 421 917
2022/20237.393 627 578 339 585 571 736 88 436 3.015 46 275 97
2023/20241.941 171 279 162 209 156 430 59 108 4 129 26 208
2024/20259.093 127 131 189 464 429 276 156 2.033 2.236 520 897 1.635
2025/202623.369 1.163 1.718 2.046 1.609 1.956 5.261 3.109 2.923 2.865 719 0 0
Totale 53.476